Accuray applies for Tomo C Chinese market clearance

By staff writers

November 1, 2022 -- Radiation therapy developer Accuray has applied to the Chinese National Medical Products Administration for market clearance for its Tomo C radiation therapy system.

The application was filed under the auspices of the CNNC-Accuray joint venture, which was established in 2019 and is based in Tianjin, China, the company said.

Tomo C offers integrated helical fan-beam imaging and radiation delivery in conventionally fractionated or ultrahypofractionated treatments, according to the firm.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking